Annual CFO
$24.79 M
-$167.00 K-0.67%
31 December 2023
Summary:
Core Laboratories NV annual cash flow from operations is currently $24.79 million, with the most recent change of -$167.00 thousand (-0.67%) on 31 December 2023. During the last 3 years, it has fallen by -$33.08 million (-57.16%). CLB annual CFO is now -91.83% below its all-time high of $303.45 million, reached on 31 December 2014.CLB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$13.10 M
-$4.05 M-23.61%
30 September 2024
Summary:
Core Laboratories NV quarterly cash flow from operations is currently $13.10 million, with the most recent change of -$4.05 million (-23.61%) on 30 September 2024. Over the past year, it has increased by +$13.31 million (+6277.83%). CLB quarterly CFO is now -86.61% below its all-time high of $97.79 million, reached on 31 December 2014.CLB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$55.20 M
+$13.31 M+31.77%
30 September 2024
Summary:
Core Laboratories NV TTM cash flow from operations is currently $55.20 million, with the most recent change of +$13.31 million (+31.77%) on 30 September 2024. Over the past year, it has increased by +$36.63 million (+197.25%). CLB TTM CFO is now -82.61% below its all-time high of $317.35 million, reached on 31 March 2015.CLB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.7% | +6277.8% | +197.3% |
| 3 y3 years | -57.2% | +9.6% | +214.0% |
| 5 y5 years | -77.8% | -49.6% | -48.0% |
CLB Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -57.2% | at low | -32.6% | +513.3% | at high | +234.6% |
| 5 y | 5 years | -77.8% | at low | -51.5% | +210.6% | -48.0% | +234.6% |
| alltime | all time | -91.8% | +954.8% | -86.6% | +210.6% | -82.6% | +1122.3% |
Core Laboratories NV Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.10 M(-23.6%) | $55.20 M(+31.8%) |
| June 2024 | - | $17.15 M(+210.1%) | $41.89 M(+25.1%) |
| Mar 2024 | - | $5.53 M(-71.5%) | $33.49 M(+35.1%) |
| Dec 2023 | $24.79 M(-0.7%) | $19.43 M(-9264.6%) | $24.79 M(+33.5%) |
| Sept 2023 | - | -$212.00 K(-102.4%) | $18.57 M(-24.6%) |
| June 2023 | - | $8.74 M(-375.8%) | $24.63 M(+49.3%) |
| Mar 2023 | - | -$3.17 M(-124.0%) | $16.50 M(-33.9%) |
| Dec 2022 | $24.96 M(-31.8%) | $13.21 M(+125.8%) | $24.96 M(+32.0%) |
| Sept 2022 | - | $5.85 M(+866.9%) | $18.90 M(-24.4%) |
| June 2022 | - | $605.00 K(-88.6%) | $25.00 M(-26.2%) |
| Mar 2022 | - | $5.29 M(-26.1%) | $33.88 M(-7.4%) |
| Dec 2021 | $36.58 M(-36.8%) | $7.15 M(-40.1%) | $36.58 M(+108.1%) |
| Sept 2021 | - | $11.95 M(+26.0%) | $17.58 M(-33.2%) |
| June 2021 | - | $9.49 M(+18.8%) | $26.32 M(-39.9%) |
| Mar 2021 | - | $7.99 M(-167.4%) | $43.83 M(-24.3%) |
| Dec 2020 | $57.87 M(-35.4%) | -$11.85 M(-157.2%) | $57.87 M(-36.4%) |
| Sept 2020 | - | $20.69 M(-23.3%) | $91.02 M(-5.5%) |
| June 2020 | - | $27.00 M(+22.6%) | $96.31 M(+11.5%) |
| Mar 2020 | - | $22.02 M(+3.4%) | $86.40 M(-3.5%) |
| Dec 2019 | $89.53 M(-19.9%) | $21.30 M(-18.0%) | $89.53 M(-15.6%) |
| Sept 2019 | - | $25.99 M(+52.2%) | $106.13 M(+2.1%) |
| June 2019 | - | $17.08 M(-32.1%) | $103.98 M(-8.7%) |
| Mar 2019 | - | $25.16 M(-33.6%) | $113.89 M(+1.8%) |
| Dec 2018 | $111.83 M(-10.0%) | $37.90 M(+59.0%) | $111.83 M(-6.7%) |
| Sept 2018 | - | $23.84 M(-11.7%) | $119.84 M(-4.8%) |
| June 2018 | - | $26.99 M(+16.9%) | $125.88 M(+7.0%) |
| Mar 2018 | - | $23.09 M(-49.7%) | $117.60 M(-5.4%) |
| Dec 2017 | $124.27 M(-5.8%) | $45.92 M(+53.7%) | $124.27 M(+22.4%) |
| Sept 2017 | - | $29.88 M(+59.7%) | $101.56 M(-4.7%) |
| June 2017 | - | $18.71 M(-37.1%) | $106.55 M(-7.8%) |
| Mar 2017 | - | $29.76 M(+28.3%) | $115.55 M(-12.4%) |
| Dec 2016 | $131.89 M(-39.8%) | $23.20 M(-33.5%) | $131.89 M(-16.5%) |
| Sept 2016 | - | $34.87 M(+25.8%) | $158.01 M(-5.2%) |
| June 2016 | - | $27.72 M(-39.9%) | $166.62 M(-10.3%) |
| Mar 2016 | - | $46.10 M(-6.6%) | $185.67 M(-15.3%) |
| Dec 2015 | $219.10 M(-27.8%) | $49.33 M(+13.5%) | $219.10 M(-18.1%) |
| Sept 2015 | - | $43.48 M(-7.0%) | $267.56 M(-10.4%) |
| June 2015 | - | $46.76 M(-41.2%) | $298.51 M(-5.9%) |
| Mar 2015 | - | $79.53 M(-18.7%) | $317.35 M(+4.6%) |
| Dec 2014 | $303.45 M(+1.8%) | $97.79 M(+31.4%) | $303.45 M(+3.5%) |
| Sept 2014 | - | $74.43 M(+13.4%) | $293.15 M(+0.1%) |
| June 2014 | - | $65.61 M(-0.0%) | $292.87 M(-0.9%) |
| Mar 2014 | - | $65.62 M(-25.0%) | $295.50 M(-0.9%) |
| Dec 2013 | $298.14 M(+25.7%) | $87.49 M(+18.0%) | $298.14 M(+0.8%) |
| Sept 2013 | - | $74.15 M(+8.7%) | $295.70 M(+8.4%) |
| June 2013 | - | $68.24 M(-0.0%) | $272.81 M(+8.4%) |
| Mar 2013 | - | $68.26 M(-19.7%) | $251.67 M(+6.1%) |
| Dec 2012 | $237.20 M(+16.2%) | $85.05 M(+65.9%) | $237.20 M(+13.3%) |
| Sept 2012 | - | $51.26 M(+8.8%) | $209.45 M(+1.1%) |
| June 2012 | - | $47.10 M(-12.4%) | $207.07 M(+3.6%) |
| Mar 2012 | - | $53.79 M(-6.1%) | $199.89 M(-2.1%) |
| Dec 2011 | $204.13 M(-0.8%) | $57.30 M(+17.2%) | $204.13 M(+11.2%) |
| Sept 2011 | - | $48.88 M(+22.4%) | $183.53 M(-4.6%) |
| June 2011 | - | $39.93 M(-31.2%) | $192.43 M(-4.5%) |
| Mar 2011 | - | $58.02 M(+58.1%) | $201.49 M(-2.1%) |
| Dec 2010 | $205.83 M | $36.70 M(-36.5%) | $205.83 M(-0.1%) |
| Sept 2010 | - | $57.77 M(+17.9%) | $206.09 M(-0.4%) |
| June 2010 | - | $48.99 M(-21.4%) | $206.97 M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $62.37 M(+68.7%) | $194.12 M(+6.7%) |
| Dec 2009 | $181.87 M(+17.2%) | $36.96 M(-37.0%) | $181.87 M(-4.3%) |
| Sept 2009 | - | $58.65 M(+62.2%) | $189.98 M(+13.0%) |
| June 2009 | - | $36.15 M(-27.9%) | $168.07 M(-6.6%) |
| Mar 2009 | - | $50.12 M(+11.2%) | $179.88 M(+15.9%) |
| Dec 2008 | $155.21 M(+23.5%) | $45.07 M(+22.7%) | $155.21 M(+4.9%) |
| Sept 2008 | - | $36.73 M(-23.4%) | $148.02 M(+6.2%) |
| June 2008 | - | $47.96 M(+88.5%) | $139.38 M(+5.6%) |
| Mar 2008 | - | $25.44 M(-32.8%) | $131.98 M(+5.0%) |
| Dec 2007 | $125.69 M(+4.5%) | $37.88 M(+34.8%) | $125.69 M(-1.8%) |
| Sept 2007 | - | $28.09 M(-30.7%) | $128.04 M(-0.4%) |
| June 2007 | - | $40.56 M(+111.7%) | $128.58 M(+12.2%) |
| Mar 2007 | - | $19.16 M(-52.4%) | $114.64 M(-4.7%) |
| Dec 2006 | $120.31 M(+60.9%) | $40.23 M(+40.5%) | $120.31 M(+21.4%) |
| Sept 2006 | - | $28.63 M(+7.5%) | $99.07 M(+2.6%) |
| June 2006 | - | $26.63 M(+7.3%) | $96.60 M(+9.9%) |
| Mar 2006 | - | $24.82 M(+30.7%) | $87.93 M(+17.6%) |
| Dec 2005 | $74.78 M(+38.0%) | $19.00 M(-27.4%) | $74.78 M(+2.8%) |
| Sept 2005 | - | $26.15 M(+45.6%) | $72.73 M(+22.5%) |
| June 2005 | - | $17.96 M(+54.0%) | $59.35 M(+6.7%) |
| Mar 2005 | - | $11.67 M(-31.2%) | $55.65 M(+2.7%) |
| Dec 2004 | $54.20 M(-9.4%) | $16.95 M(+32.7%) | $54.20 M(-3.4%) |
| Sept 2004 | - | $12.78 M(-10.4%) | $56.13 M(-5.1%) |
| June 2004 | - | $14.26 M(+39.7%) | $59.15 M(-8.7%) |
| Mar 2004 | - | $10.21 M(-45.9%) | $64.76 M(+8.2%) |
| Dec 2003 | $59.85 M(+38.7%) | $18.88 M(+19.5%) | $59.85 M(+6.2%) |
| Sept 2003 | - | $15.80 M(-20.5%) | $56.37 M(+16.7%) |
| June 2003 | - | $19.87 M(+275.0%) | $48.31 M(+13.8%) |
| Mar 2003 | - | $5.30 M(-65.6%) | $42.46 M(-1.6%) |
| Dec 2002 | $43.16 M(+52.4%) | $15.40 M(+99.0%) | $43.16 M(+9.7%) |
| Sept 2002 | - | $7.74 M(-44.8%) | $39.34 M(+11.3%) |
| June 2002 | - | $14.02 M(+133.3%) | $35.36 M(+31.4%) |
| Mar 2002 | - | $6.01 M(-48.1%) | $26.91 M(-5.0%) |
| Dec 2001 | $28.32 M(+290.1%) | $11.58 M(+208.3%) | $28.32 M(+14.5%) |
| Sept 2001 | - | $3.76 M(-32.5%) | $24.74 M(+22.9%) |
| June 2001 | - | $5.56 M(-25.0%) | $20.13 M(+200.7%) |
| Mar 2001 | - | $7.42 M(-7.3%) | $6.69 M(-7.8%) |
| Dec 2000 | $7.26 M(+39.4%) | $8.01 M(-1029.7%) | $7.26 M(+998.2%) |
| Sept 2000 | - | -$861.00 K(-89.1%) | $661.00 K(-91.7%) |
| June 2000 | - | -$7.87 M(-198.6%) | $7.99 M(-49.7%) |
| Mar 2000 | - | $7.99 M(+467.5%) | $15.90 M(+205.3%) |
| Dec 1999 | $5.21 M(-12.3%) | $1.41 M(-78.2%) | $5.21 M(-2072.3%) |
| Sept 1999 | - | $6.47 M(>+9900.0%) | -$264.00 K(-102.9%) |
| June 1999 | - | $37.00 K(-101.4%) | $8.97 M(+89.5%) |
| Mar 1999 | - | -$2.70 M(-33.5%) | $4.73 M(-20.3%) |
| Dec 1998 | $5.94 M(-304.7%) | -$4.06 M(-125.9%) | $5.94 M(+60.4%) |
| Sept 1998 | - | $15.70 M(-473.8%) | $3.70 M(-285.0%) |
| June 1998 | - | -$4.20 M(+180.0%) | -$2.00 M(-63.0%) |
| Mar 1998 | - | -$1.50 M(-76.2%) | -$5.40 M(+86.2%) |
| Dec 1997 | -$2.90 M(-122.1%) | -$6.30 M(-163.0%) | -$2.90 M(-125.0%) |
| Sept 1997 | - | $10.00 M(-231.6%) | $11.60 M(+222.2%) |
| June 1997 | - | -$7.60 M(-860.0%) | $3.60 M(-73.9%) |
| Mar 1997 | - | $1.00 M(-87.8%) | $13.80 M(+5.3%) |
| Dec 1996 | $13.10 M(+70.1%) | $8.20 M(+310.0%) | $13.10 M(+167.3%) |
| Sept 1996 | - | $2.00 M(-23.1%) | $4.90 M(+69.0%) |
| June 1996 | - | $2.60 M(+766.7%) | $2.90 M(+866.7%) |
| Mar 1996 | - | $300.00 K | $300.00 K |
| Dec 1995 | $7.70 M | - | - |
FAQ
- What is Core Laboratories NV annual cash flow from operations?
- What is the all time high annual CFO for Core Laboratories NV?
- What is Core Laboratories NV annual CFO year-on-year change?
- What is Core Laboratories NV quarterly cash flow from operations?
- What is the all time high quarterly CFO for Core Laboratories NV?
- What is Core Laboratories NV quarterly CFO year-on-year change?
- What is Core Laboratories NV TTM cash flow from operations?
- What is the all time high TTM CFO for Core Laboratories NV?
- What is Core Laboratories NV TTM CFO year-on-year change?
What is Core Laboratories NV annual cash flow from operations?
The current annual CFO of CLB is $24.79 M
What is the all time high annual CFO for Core Laboratories NV?
Core Laboratories NV all-time high annual cash flow from operations is $303.45 M
What is Core Laboratories NV annual CFO year-on-year change?
Over the past year, CLB annual cash flow from operations has changed by -$167.00 K (-0.67%)
What is Core Laboratories NV quarterly cash flow from operations?
The current quarterly CFO of CLB is $13.10 M
What is the all time high quarterly CFO for Core Laboratories NV?
Core Laboratories NV all-time high quarterly cash flow from operations is $97.79 M
What is Core Laboratories NV quarterly CFO year-on-year change?
Over the past year, CLB quarterly cash flow from operations has changed by +$13.31 M (+6277.83%)
What is Core Laboratories NV TTM cash flow from operations?
The current TTM CFO of CLB is $55.20 M
What is the all time high TTM CFO for Core Laboratories NV?
Core Laboratories NV all-time high TTM cash flow from operations is $317.35 M
What is Core Laboratories NV TTM CFO year-on-year change?
Over the past year, CLB TTM cash flow from operations has changed by +$36.63 M (+197.25%)